Reata Pharmaceuticals Inc (RETA)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
02-Mar-20 3:02 PM
View: 
Castellanos Elaine
VP, Chief Accounting Officer
Reata Pharmaceuticals Inc (RETA) 02-Mar-20Conversion 2,000----13%
15.15K to 17.15K
02-Mar-20 3:02 PM
View: 
Castellanos Elaine
VP, Chief Accounting Officer
Reata Pharmaceuticals Inc (RETA) 02-Mar-20Sale (Planned) 2,000$194.32$388,640.00(12%)
17.15K to 15.15K
02-Jan-20 4:15 PM
View: 
Traweek James W Jr
10% Owner
Reata Pharmaceuticals Inc (RETA) 30-Dec-19Conversion 30,000----< 1%
3.12M to 3.15M
17-Dec-19 5:30 PM
View: 
Wilson Jason Douglas
Executive VP of Operations
Reata Pharmaceuticals Inc (RETA) 16-Dec-19Conversion 10,000----77%
12.95K to 22.95K
17-Dec-19 5:30 PM
View: 
Wilson Jason Douglas
Executive VP of Operations
Reata Pharmaceuticals Inc (RETA) 16-Dec-19Private Sale (Planned) 10,000$203.26$2,032,590.00(44%)
22.95K to 12.95K
17-Dec-19 5:21 PM
View: 
Meyer Colin John
Chief Medical Officer
Reata Pharmaceuticals Inc (RETA) 16-Dec-19Conversion 69,828----257%
27.17K to 97.0K
17-Dec-19 5:30 PM
View: 
Wilson Jason Douglas
Executive VP of Operations
Reata Pharmaceuticals Inc (RETA) 16-Dec-19Conversion 5,600----76%
7.35K to 12.95K
16-Dec-19 4:16 PM
View: 
McGaughy R Kent Jr
Director
10% Owner
Reata Pharmaceuticals Inc (RETA) 12-Dec-19Conversion 30,478----< 1%
3.1M to 3.13M
16-Dec-19 4:17 PM
View: 
Traweek James W Jr
10% Owner
Reata Pharmaceuticals Inc (RETA) 12-Dec-19Conversion
Duplicate
30,478----< 1%
3.09M to 3.12M
03-Dec-19 4:03 PM
View: 
Castellanos Elaine
VP, Chief Accounting Officer
Reata Pharmaceuticals Inc (RETA) 02-Dec-19Conversion 2,000----13%
15.15K to 17.15K
03-Dec-19 4:03 PM
View: 
Castellanos Elaine
VP, Chief Accounting Officer
Reata Pharmaceuticals Inc (RETA) 02-Dec-19Private Sale (Planned) 2,000$194.24$388,480.00(12%)
17.15K to 15.15K
09-Jan-20 10:00 PM
View: 
Bass James Edward
Director
Reata Pharmaceuticals Inc (RETA) 20-Nov-19Gift 6,000----(6%)
105.08K to 99.08K
05-Dec-19 5:22 PM
View: 
Rose William
Director
10% Owner
Reata Pharmaceuticals Inc (RETA) 20-Nov-19Private Sale 6,591$212.53$1,400,770.00(< 1%)
1.11M to 1.1M
05-Dec-19 5:22 PM
View: 
Rose William
Director
10% Owner
Reata Pharmaceuticals Inc (RETA) 19-Nov-19Private Sale 2,000$210.00$420,000.00(< 1%)
1.11M to 1.11M
18-Nov-19 5:20 PM
View: 
Cpmg Inc
Director
10% Owner
Reata Pharmaceuticals Inc (RETA) 18-Nov-19Purchase 40,218$183.00$7,359,890.001%
3.02M to 3.06M
18-Nov-19 5:21 PM
View: 
McGaughy R Kent Jr
Director
10% Owner
Reata Pharmaceuticals Inc (RETA) 18-Nov-19Purchase
Duplicate
40,218$183.00$7,359,890.001%
3.06M to 3.1M
18-Nov-19 5:23 PM
View: 
Traweek James W Jr
10% Owner
Reata Pharmaceuticals Inc (RETA) 18-Nov-19Purchase
Duplicate
40,218$183.00$7,359,890.001%
3.05M to 3.09M
05-Dec-19 5:22 PM
View: 
Rose William
Director
10% Owner
Reata Pharmaceuticals Inc (RETA) 18-Nov-19Private Sale 1,000$202.04$202,040.00(< 1%)
1.11M to 1.11M
05-Dec-19 5:22 PM
View: 
Rose William
Director
10% Owner
Reata Pharmaceuticals Inc (RETA) 08-Nov-19Conversion 15,869----1%
1.09M to 1.11M
30-Oct-19 11:32 AM
View: 
Castellanos Elaine
VP, Chief Accounting Officer
Reata Pharmaceuticals Inc (RETA) 28-Oct-19Private Sale (Planned) 4,000$200.00$800,000.00(21%)
19.15K to 15.15K
30-Oct-19 11:32 AM
View: 
Castellanos Elaine
VP, Chief Accounting Officer
Reata Pharmaceuticals Inc (RETA) 28-Oct-19Conversion 4,000----26%
15.15K to 19.15K
28-Oct-19 4:41 PM
View: 
Castellanos Elaine
VP, Chief Accounting Officer
Reata Pharmaceuticals Inc (RETA) 25-Oct-19Conversion 2,000----13%
15.15K to 17.15K
28-Oct-19 4:41 PM
View: 
Castellanos Elaine
VP, Chief Accounting Officer
Reata Pharmaceuticals Inc (RETA) 25-Oct-19Conversion 3,213----27%
11.93K to 15.15K
28-Oct-19 4:41 PM
View: 
Castellanos Elaine
VP, Chief Accounting Officer
Reata Pharmaceuticals Inc (RETA) 25-Oct-19Private Sale (Planned) 2,000$190.00$380,000.00(12%)
17.15K to 15.15K
21-Oct-19 3:32 PM
View: 
Castellanos Elaine
Principal Accounting Officer
Reata Pharmaceuticals Inc (RETA) 18-Oct-19Private Sale (Planned) 2,000$170.00$340,000.00(14%)
13.93K to 11.93K
21-Oct-19 3:32 PM
View: 
Castellanos Elaine
Principal Accounting Officer
Reata Pharmaceuticals Inc (RETA) 18-Oct-19Conversion 2,000----17%
11.93K to 13.93K
21-Oct-19 3:39 PM
View: 
Wilson Jason Douglas
Executive VP of Operations
Reata Pharmaceuticals Inc (RETA) 17-Oct-19Conversion 10,000----136%
7.35K to 17.35K
21-Oct-19 3:39 PM
View: 
Wilson Jason Douglas
Executive VP of Operations
Reata Pharmaceuticals Inc (RETA) 17-Oct-19Private Sale (Planned) 10,000$170.00$1,700,000.00(58%)
17.35K to 7.35K
15-Oct-19 4:03 PM
View: 
Wilson Jason Douglas
Executive VP of Operations
Reata Pharmaceuticals Inc (RETA) 15-Oct-19Conversion 15,000----204%
7.35K to 22.35K
15-Oct-19 4:03 PM
View: 
Wilson Jason Douglas
Executive VP of Operations
Reata Pharmaceuticals Inc (RETA) 15-Oct-19Private Sale (Planned) 15,000$146.13$2,191,960.00(67%)
22.35K to 7.35K
17-Oct-19 4:51 PM
View: 
Castellanos Elaine
Principal Accounting Officer
Reata Pharmaceuticals Inc (RETA) 15-Oct-19Private Sale (Planned) 14,000$147.59$2,066,240.00(54%)
25.93K to 11.93K
17-Oct-19 4:51 PM
View: 
Castellanos Elaine
Principal Accounting Officer
Reata Pharmaceuticals Inc (RETA) 15-Oct-19Conversion 14,000----117%
11.93K to 25.93K
15-Oct-19 3:52 PM
View: 
Castellanos Elaine
Principal Accounting Officer
Reata Pharmaceuticals Inc (RETA) 14-Oct-19Conversion 3,000----25%
11.93K to 14.93K
15-Oct-19 4:03 PM
View: 
Wilson Jason Douglas
Executive VP of Operations
Reata Pharmaceuticals Inc (RETA) 14-Oct-19Conversion 15,000----204%
7.35K to 22.35K
15-Oct-19 4:03 PM
View: 
Wilson Jason Douglas
Executive VP of Operations
Reata Pharmaceuticals Inc (RETA) 14-Oct-19Private Sale (Planned) 15,000$100.00$1,500,000.00(67%)
22.35K to 7.35K
15-Oct-19 3:52 PM
View: 
Castellanos Elaine
Principal Accounting Officer
Reata Pharmaceuticals Inc (RETA) 14-Oct-19Private Sale (Planned) 3,000$105.00$315,000.00(20%)
14.93K to 11.93K
15-Oct-19 3:52 PM
View: 
Castellanos Elaine
Principal Accounting Officer
Reata Pharmaceuticals Inc (RETA) 11-Oct-19Conversion 9,795----458%
2.14K to 11.93K
30-Sep-19 3:18 PM
View: 
Huff James Warren
Chief Executive Officer
Director
Reata Pharmaceuticals Inc (RETA) 27-Sep-19Market Sale 63,000$86.61$5,456,120.00(36%)
172.82K to 109.82K
30-Sep-19 3:18 PM
View: 
Huff James Warren
Chief Executive Officer
Director
Reata Pharmaceuticals Inc (RETA) 23-Sep-19Gift 19,500----(10%)
192.32K to 172.82K
30-Sep-19 3:18 PM
View: 
Huff James Warren
Chief Executive Officer
Director
Reata Pharmaceuticals Inc (RETA) 23-Sep-19Gift 12,500----7%
179.82K to 192.32K
10-Sep-19 3:46 PM
View: 
Castellanos Elaine
Principal Accounting Officer
Reata Pharmaceuticals Inc (RETA) 06-Sep-19Conversion 2,000----94%
2.14K to 4.14K
10-Sep-19 3:46 PM
View: 
Castellanos Elaine
Principal Accounting Officer
Reata Pharmaceuticals Inc (RETA) 06-Sep-19Market Sale (Planned) 2,000$85.00$170,000.00(48%)
4.14K to 2.14K
16-Aug-19 3:09 PM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 15-Aug-19Conversion 4,000----100%
0 to 4.0K
16-Aug-19 3:09 PM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 15-Aug-19Sale (Planned) 4,000$72.68$290,735.00(100%)
4.0K to 0
17-Jul-19 1:01 PM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 15-Jul-19Conversion 4,000----100%
0 to 4.0K
17-Jul-19 1:01 PM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 15-Jul-19Market Sale (Planned) 4,000$84.64$338,556.00(100%)
4.0K to 0
19-Jun-19 4:06 PM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 17-Jun-19Conversion 4,000----100%
0 to 4.0K
19-Jun-19 4:06 PM
View: 
Wilson Jason Douglas
Chief Financial Officer
Reata Pharmaceuticals Inc (RETA) 17-Jun-19Market Sale (Planned) 4,000$83.54$334,177.00(100%)
4.0K to 0
05-Jun-19 1:10 PM
View: 
Castellanos Elaine
Principal Accounting Officer
Reata Pharmaceuticals Inc (RETA) 03-Jun-19Conversion 2,000----94%
2.14K to 4.14K
05-Jun-19 1:10 PM
View: 
Castellanos Elaine
Principal Accounting Officer
Reata Pharmaceuticals Inc (RETA) 03-Jun-19Market Sale (Planned) 2,000$85.20$170,400.00(48%)
4.14K to 2.14K